Abstract:The mechanism underlying the higher prevalence of hypertension in diabetes remains unclear. We hypothesized that blunted tubuloglomerular feedback (TGF) mediated by the neuronal nitric oxide synthesis (NOS1) β in the macula densa promotes glomerular hyperfiltration in diabetes, whereas inadequate NOS1β in the macula densa restricts glomerular hyperfiltration, induces hypertension and exacerbates diabetic kidney injury. First, we measured the protein levels of NOS1β in the renal cortex, which was 6.5±1.2 fold higher in db/db mice than in db/+ mice (n=5, p<0.01). Then, in isolated and perfused juxtaglomerular apparatus, we measured TGF-induced NO generation by the macula densa, which was 115.4±9.8 Units/min in db/+ mice and 161.5±12.7 Units/min in db/db mice (n=5, p<0.01). We next measured TGF in vivo using micropuncture, which was 3.7±0.4 mmHg in db/db mice and 5.3±0.3 mmHg in db/+ mice (n=5, p<0.05). Then we developed a macula densa specific NOS1 knockout db/db mouse line (KO) (Lepr db/db ; NKCC2 cre ; NOS1 flox/flox ). Littermate db/db (Lepr db/db ; NOS1 flox/flox ) and db/+ (Lepr db/+ ; NOS1 flox/flox ) mice serve as diabetic and non-diabetic controls. Glomerular filtration rate (GFR) was 236±18 μl/min in db/+ mice, and significantly increased to 375±12 and 284±11 μl/min in the db/db and KO mice (n=4-5, p<0.01). Telemetric mean arterial pressure (MAP) was 97.1±3.5 and 103.6±5.2 mmHg in db/+ and db/db mice, and significantly raised to 124.4±8.1 mmHg in the KO mice (n=4-5, p<0.01). Proteinuria increased by 70 and 120 folds in the db/db and KO mice compared with db/+ mice (n=4, p<0.01). The kidney histology was assessed with light and transmission electron microscopy in the mice at age of 24 weeks. The diabetic kidney injury score was 0.37±0.16 in the db/+ mice, and significantly increased to 1.14±0.2 and 2.37±0.67 in the db/db and KO mice (n=5, p<0.01). In conclusion, upregulation of the macula densa NOS1 blunts TGF response and promotes elevation of GFR in diabetes. Contrary to popular belief about glomerular hyperfiltration in diabetes, our data suggest that directly limiting the increase in GFR by enhancement of TGF response is detrimental, which induces hypertension and exacerbates diabetic kidney injury.

Low TGFβ1 expression prevents and high expression exacerbates diabetic nephropathy in mice

Latent TGF-β1 Protects Against Diabetic Kidney Disease Via Arkadia/Smad7 Signaling

Transforming Growth Factor Beta (Tgf-Β) Mediates Cardiac Fibrosis and Induces Diabetic Cardiomyopathy

Protective Role of Low-Dose TGF-β1 in Early Diabetic Nephropathy Induced by Streptozotocin.

TNF-? and IL-1? Promote Renal Podocyte Injury in T2DM Rats by Decreasing Glomerular VEGF/eNOS Expression Levels and Altering Hemodynamic Parameters

Neutralization of TGF-β by Anti-TGF-β Antibody Attenuates Kidney Hypertrophy and the Enhanced Extracellular Matrix Gene Expression in STZ-Induced Diabetic Mice

The Renal TGF-β System in the db/db Mouse Model of Diabetic Nephropathy

TGF-β signaling in diabetic nephropathy: An update

Regulatory mechanism of TGF-β1/SGK1 pathway in tubulointerstitial fibrosis of diabetic nephropathy

Mice overexpressing latent TGF-β1 are protected against renal fibrosis in obstructive kidney disease

Mice Overexpressing Latent Tgf-Beta 1 Are Protected Against Renal Fibrosis In Obstructive Kidney Disease

Abstract 049: Prevention of Glomerular Hyperfiltration by Enhancement of Tubuloglomerular Feedback Response Induces Hypertension and Exacerbates Diabetic Kidney Injury

Transform growth factor-β1 mRNA expression of PBMN in patients with diabetic nephropathy

TFPI2 suppresses the interaction of TGF-β2 pathway regulators to promote endothelial-mesenchymal transition in diabetic nephropathy

Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy

Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-β) and related molecules

Dapagliflozin Attenuates Renal Tubulointerstitial Fibrosis Associated With Type 1 Diabetes by Regulating STAT1/TGFβ1 Signaling

TAB1 regulates glycolysis and activation of macrophages in diabetic nephropathy

FGF1ΔHBS delays the progression of diabetic nephropathy in late-stage type 2 diabetes mouse model by alleviating renal inflammation, fibrosis, and apoptosis

Smad2 Phosphorylation in Diabetic Kidney Tubule Epithelial Cells is Associated with Modulation of Several Transforming Growth Factor-β Family Members.

FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy